Liminatus Pharma Statistics
NASDAQ: LIMNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.76+0.07 (+1.90%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Liminatus Pharma by the numbers
Liminatus Pharma has a market capitalization of $5.1 million based on 1.34M shares outstanding. With trailing EPS of $-23.50, Liminatus Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.8% below its 50-day average and 72.6% below its 200-day average.
Average daily trading volume is 453.28K shares, or about $1.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LIMN valuation vs. peer median
| Metric | LIMN | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.05M | $4.06M | +24% |
| Avg. volume | 453.28K | 5.28M | -91% |
Peer median across 8 companies: PMCB, CLDI, CELZ, BTTC, SLXN, VIVS, AIM, HLSQ.
Valuation
- Market cap
- $5.05M
- EPS (TTM)
- $-23.50
- Shares outstanding
- 1.34M
Price and trading
- Previous close
- 3.69
- Open
- 3.55
- Day range
- 3.55 – 3.77
- 52-week range
- 3.29 – 141.50
- Beta
- —
- Volume
- 16.84K
- Average volume
- 453.28K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 5.05M
- Eps
- -23.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 141.50
- Week52 Low
- 3.29
- Avg Volume
- 453.28K
- Shares Outstanding
- 1.34M
- Ma50
- 4.52
- Ma200
- 13.73
- Pct From52w High
- -97.34%
- Pct From52w Low
- 14.29%